{"name":"Endovasc","slug":"endovasc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNcVBEM1g5dUZEY1VKMnlIWGdxQ3REVWVYc1NGeDJ0LWExQlVQV3pNd0d1SnZ0V3pPbzN0LXVqellScF9WY05xS1cyQ0RLNFA1d081T054U2hWOEt2Ym1fUFdnOTE5ak5YbnE0UWg2YkQ2NV9ndzNZdk1rZmo4M0xrUS15Yk84WXdiVmkzdVNXRTdtSWcxekxLSExMUHAzQ3dEYzd4V1RlenNTQlB6bzZ6YmYxVTZpMnIzaVlaZ2ZHcmIxX3ZaNlQ0UHQzSUIwZHBoVUxrejNIcmdtRlRjeXc4WERzRDgtenBiQ3pR?oc=5","date":"2026-01-05","type":"deal","source":"PR Newswire","summary":"W. L. GORE & ASSOCIATES TO ACQUIRE CONFORMAL MEDICAL, EXPANDING ITS PRESENCE IN ENDOVASCULAR TREATMENTS - PR Newswire","headline":"W. L. GORE & ASSOCIATES TO ACQUIRE CONFORMAL MEDICAL, EXPANDING ITS PRESENCE IN ENDOVASCULAR TREATMENTS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQak1xNXNBbHJkV2VpMUVBVzhFSHdpWXJDZ282cm84YkRlckR2VEo4TFkzS3hpT3ViQy05UFBqU05uQjAyN0ltYWdkWHg5TW9QX3dUVURiT2FUc01kUlZ3ZjRSTG9LSlZvU3BGQy1ZUUIwcEd2NjYyQUZwejJTOWN5N2ZOVVZ3VmRYcEE?oc=5","date":"2025-12-30","type":"regulatory","source":"American Hospital Association","summary":"FDA identifies, issues Class 1 recalls - American Hospital Association","headline":"FDA identifies, issues Class 1 recalls","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNeGdyUlpBa2V6REdoQVNQX0d6MWhEWGZ1RGh3dXo0ek83V1ljWVo1WVMwd2UwdlNwdDZZd3dzeDBSM1JYMzVLS2kwRVhod0kzWE1TbXF2Yl96cERBY0xKLWhLMDQ2S3FEM3EzX3c5cU1IQXFMUXdqMXBhQzdfa0pnUGt6VTA5cFhmWVdEdjhPRVpKOUVzZWprUUt1eHF0dXJObEkyU1lNbHZkYWJkdlNqYloxS040eVdNdDVWRDBuOWc0THg4WTN1elB5cGsyMkRrNXB4TU1GLTMxM2t1dDRwMUlTVFd5cmlFSlE?oc=5","date":"2024-12-11","type":"trial","source":"BioSpace","summary":"GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz - BioSpace","headline":"GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPRGNaR3ZiTWxQUERKRWRTY2lhbEFzbmpVUl9jdFl4LVVQajBPUldkcTNkdTJLNkJTRmYyc0FIME9IUGc1SXUzb2N6RlNpRzd1M0d1d3J4LWJHVm1LQmhwRk5lRTNSUUdQa1RMaHZUV2xnYWVBb2t5VkZsajNsajdlMFJFa0J4eFZNMlFDd3dUM3lmc2R0cUtXZTk4T3NKZUZLRDdaNUZzMlYtbUFxX0RzdFFsYXhqdXJPUmxXQ1UtM09rSXJmUTZtb3JOSjlOZ9IBzgFBVV95cUxPRGNaR3ZiTWxQUERKRWRTY2lhbEFzbmpVUl9jdFl4LVVQajBPUldkcTNkdTJLNkJTRmYyc0FIME9IUGc1SXUzb2N6RlNpRzd1M0d1d3J4LWJHVm1LQmhwRk5lRTNSUUdQa1RMaHZUV2xnYWVBb2t5VkZsajNsajdlMFJFa0J4eFZNMlFDd3dUM3lmc2R0cUtXZTk4T3NKZUZLRDdaNUZzMlYtbUFxX0RzdFFsYXhqdXJPUmxXQ1UtM09rSXJmUTZtb3JOSjlOZw?oc=5","date":"2021-08-18","type":"pipeline","source":"Indian Pharma Post","summary":"Apollo Children’s hospital saves new born with rare brain vascular malformation - Indian Pharma Post","headline":"Apollo Children’s hospital saves new born with rare brain vascular malformation","sentiment":"neutral"},{"date":"2007-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: ENDOVASC 10-Q 3-31-2007","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2007-05-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ENDOVASC 8-K 5-14-07","headline":"SEC 8-K: ENDOVASC 8-K 5-14-07","sentiment":"neutral"},{"date":"2007-04-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ENDOVASC 8-K 4-25-2007","headline":"SEC 8-K: ENDOVASC 8-K 4-25-2007","sentiment":"neutral"},{"date":"2007-02-20","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: ENDOVASC 10-Q 12-31-2006","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2007-01-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ENDOVASC, INC. 8-K 01-10-2007","headline":"SEC 8-K: ENDOVASC, INC. 8-K 01-10-2007","sentiment":"neutral"},{"date":"2006-12-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ENDOVASC 8-K 12-13-2006","headline":"SEC 8-K: ENDOVASC 8-K 12-13-2006","sentiment":"neutral"},{"date":"2006-11-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ENDOVASC 8-K 11-28-2006","headline":"SEC 8-K: ENDOVASC 8-K 11-28-2006","sentiment":"neutral"},{"date":"2006-11-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ENDOVASC 8-K 11-16-2006","headline":"SEC 8-K: ENDOVASC 8-K 11-16-2006","sentiment":"neutral"},{"date":"2006-11-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: ENDOVASC 10-Q 9-30-2006","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNQmJTdHVWSk1jcGpibDNfMXMyMUlSZmczQTF4bkZtSzd5bjlCenF1ZHZWS2IwOWdFajh6d09zWTJyNS1YRkZJQy1nVVlFVi1rNlVhTWRLMWJrcWNHWEVPUms4VW4xeVF3ajlPTFYtdWdHYkRjRzVsbWlKQjhDcmcyemw0ZmZiTURCY2JTQXE2bUgtREZVV0pqcU4wZw?oc=5","date":"2006-09-06","type":"trial","source":"Contract Pharma","summary":"Pyramid Labs Completes Manufacturing for Endovasc Trial - Contract Pharma","headline":"Pyramid Labs Completes Manufacturing for Endovasc Trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}